Publications by authors named "M J Bolster"
Lessons on Telemedicine in Rheumatology: Thinking beyond the Coronavirus Disease 2019 Pandemic.
Rheum Dis Clin North Am
February 2025
During the COVID-19 pandemic, telemedicine was rapidly deployed to meet the clinical needs of patients with rheumatic diseases worldwide. Rheumatologists were forced to care for patients with all rheumatic diseases, regardless of disease activity, and limited evidence was available to guide provider decision-making regarding telemedicine appropriateness for outpatient rheumatology encounters. As the COVID-19 pandemic progressed, the ongoing provision of rheumatology telemedicine care in the U.
View Article and Find Full Text PDFArticle Synopsis
- Patients with osteoporosis and advanced chronic kidney disease (CKD) are at increased risk for low calcium levels (hypocalcemia) when starting denosumab, but it's uncertain if later doses carry the same risk.
- An observational study analyzed data from 10,398 patients to determine how denosumab affects calcium levels with each dose, measuring changes in serum calcium and the incidence of hypocalcemia.
- Results showed that while the first dose significantly lowered calcium levels, subsequent doses had a smaller effect, particularly in patients with severe CKD (GFR < 30 ml/min).
Background/objectives: Early childhood can be a stressful period for families with a significant impact on parents' mental health, the child's healthy development, and the development of a secure mother-child attachment. The goal of the cross-sectional study part of SKKIPPI was to assess the occurrence of psychosocial stress and mental health disorders in parents as well as in their offspring in early childhood in three German regions.
Methods: Based on random samples from three residents' registration offices, parents with infants aged up to 12 months were invited to participate.
Objective: We provide evidence-based recommendations regarding the treatment of interstitial lung disease (ILD) in adults with systemic autoimmune rheumatic diseases (SARDs).
Methods: We developed clinically relevant population, intervention, comparator, and outcomes questions. A systematic literature review was then performed, and the available evidence was rated using the Grading of Recommendations, Assessment, Development, and Evaluation methodology.